1. The University of Texas MD Anderson Cancer Center, Houston, TX;
2. Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, TX;
3. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX;
4. University of Colorado Anschutz Medical Campus, Aurora, CO;
5. Foundation Medicine, Inc., Cambridge, MA;
6. The Ohio State University Comprehensive Cancer Center, Columbus, OH;
7. The University of Chicago, Chicago, IL;
8. Emory University, Atlanta, GA;
9. Department of Investigational Cancer Therapeutics (Phase 1 Program), Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;